-
COVID-19: E-commerce firms step up efforts to protect associates, ensure deliveries
According to senior executives in the industry, demand in categories like grocery, essential items like sanitisers and masks, books, consumer electronics and appliances has gone up in the past few weeks
-
Problem not of COVID vaccine shortage but of planning: Centre
Union Health Secretary Rajesh Bhushan said so far states and UTs have received 13,10,90,370 vaccine doses, out of which the total consumption, including wastage, has been 11,43,69,677
-
Non-life insurers witness 5% rise in gross direct premium collection in FY21
The gross direct premium written by the non-life insurance companies witnessed a 5.2% increase in 2020-21 to Rs 1,98,734.68 crore, data from Irdai showed
-
Covid-19: Arvind Kejriwal appeals for plasma donation
Delhi CM Arvind Kejriwal said plasma stocks to treat COVID-19 patients are running very low and appealed to those who have recovered from the infection to be proactive in donating it
-
US recommends ‘pause’ for J&J vaccine over clot reports
The US is recommending a 'pause' in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots
-
Excise duty cut on petrol, diesel: Here’s what the CBIC Chairman has to say
The government will look to reduce prices of petrol and diesel through a cut in taxes when the time comes, says CBIC Chairman M Ajit Kumar
-
HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trials
The Department of Biotechnology has approved additional funding towards clinical studies of India's first of its kind' mRNA-based COVID-19 vaccine, HGCO19
-
Ordered probe of WhatsApp policy on competition aspect: CCI to HC
WhatsApp's new privacy policy would lead to excessive data collection and stalking of consumers for targeted advertising to bring in more users and is, therefore, alleged abuse of dominant position, says CCI
-
Indirect tax revenue up 12% at Rs 10.71 lakh crore in FY21
In the Revised Estimates for 2020-21, the target was set at Rs 9.89 lakh crore
-
Centre fast-tracks emergency approval of foreign-produced COVID-19 vaccines
The move will expand the basket of vaccines for domestic use
